Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen S Gottlieb

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Circulation. Heart Failure|March 23, 2012
Using and misusing statistics: what do we know about the effects of race on the impact of β-blockers?Stephen S Gottlieb
Journal of the American College of Cardiology|May 28, 2011
Diuretics: are our ideas based on knowledge?Stephen S Gottlieb
Current Heart Failure Reports|September 4, 2008
Adenosine A1 antagonists and the cardiorenal syndromeStephen S Gottlieb
Journal of the American College of Cardiology|May 14, 2003
The neurohormonal paradigm: have we gone too far?Stephen S Gottlieb
Journal of Cardiac Failure|February 11, 2005
The impact of finally publishing a negative study: new conclusions about endothelin antagonistsStephen S Gottlieb
Journal of Cardiac Failure|July 20, 2016
Surrogate Endpoints: Not the Real ThingStephen S Gottlieb
JACC. Heart Failure|April 29, 2017
Theory and Fact: Revisiting Association and CausationStephen S Gottlieb
Journal of the American College of Cardiology|January 24, 2009
Prognostic indicators: useful for clinical care?Stephen S Gottlieb
Journal of Cardiac Failure|July 2, 2014
Walking the line of euvolemiaKristin Watson, Stephen S Gottlieb
Journal of the American College of Cardiology|August 29, 2020
Consider Everything When Prescribing Sacubitril/Valsartan: Perfection Is the Enemy of GoodStephen S Gottlieb, Talha Ahmed
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Circulation. Heart Failure|March 23, 2012
Using and misusing statistics: what do we know about the effects of race on the impact of β-blockers?Stephen S Gottlieb
Journal of the American College of Cardiology|May 28, 2011
Diuretics: are our ideas based on knowledge?Stephen S Gottlieb
Current Heart Failure Reports|September 4, 2008
Adenosine A1 antagonists and the cardiorenal syndromeStephen S Gottlieb
Journal of the American College of Cardiology|May 14, 2003
The neurohormonal paradigm: have we gone too far?Stephen S Gottlieb
Journal of Cardiac Failure|February 11, 2005
The impact of finally publishing a negative study: new conclusions about endothelin antagonistsStephen S Gottlieb
Journal of Cardiac Failure|July 20, 2016
Surrogate Endpoints: Not the Real ThingStephen S Gottlieb
JACC. Heart Failure|April 29, 2017
Theory and Fact: Revisiting Association and CausationStephen S Gottlieb
Journal of the American College of Cardiology|January 24, 2009
Prognostic indicators: useful for clinical care?Stephen S Gottlieb
Journal of Cardiac Failure|July 2, 2014
Walking the line of euvolemiaKristin Watson, Stephen S Gottlieb
Journal of the American College of Cardiology|August 29, 2020
Consider Everything When Prescribing Sacubitril/Valsartan: Perfection Is the Enemy of GoodStephen S Gottlieb, Talha Ahmed
Pageof 13